DOHA: Health care is at the forefront of Qatar’s research initiatives, according to Dr. Faleh Mohammed Hussein Ali, Assistant Secretary General for Policy Affairs, Supreme Council of Health (SCH). He was delivering the keynote address at the Qatar Foundation -Annual Research Forum, yesterday
“Scientific research is a tool unprecedented in the country’s health care field. All the research initiatives in Qatar focus on improving the health care, which is why they are based on researches,” he said.
The success achieved in the country so far can be attributable to scientist and researchers, who have dedicated their time to advancing research, he stressed.
“Science will play a major role in health care sector as we are already witnessing new research advances in top killer diseases such as cancer, obesity and heart diseases. Scientific research has resulted in many achievements, which prompted the SCH to take action by issuing practice ethics. The council has set a code of conducts for ethical research and has also launched a national scientific research committee,” he said.
While highlighting some of the provisions of the Qatar National Development Strategy and Qatar National Vision 2030, Dr Ali reiterated that one of the aims of both programmes were to produce best quality of research in both medical and biomedical fields, in order to have healthier society.
Meanwhile, Dr Moncef Slaoui, Chairman of R&D, GlaxoSmithKline in his speech stressed that financial success and global health, which many of the pharmaceutical companies belives cannot go together, are compatible.
“Financial benefits and research for health in pharmaceutical companies are compatible. Companies should ensure the health of patients first and then only stakeholders, this can surely have a positive impact on business,” Dr Slaoui stressed.
Follow us on our social media channels: